ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,365Medicare Part D Prescriptions Filled, Including Refills

Rank: 730 out of 3647

$663K Total Retail Price of All Prescriptions

Rank: 627 out of 3647

728 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 728 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 728 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 9,739 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 448 386 1 1
AMLODIPINE BESYLATE 376 342 2 2
METFORMIN HCL 315 287 3 6
LISINOPRIL 301 244 4 4
LEVOTHYROXINE SODIUM 295 255 5 5
METOPROLOL TARTRATE 289 270 6 7
OMEPRAZOLE 262 244 7 3
MELOXICAM 226 191 8 33
HYDROCHLOROTHIAZIDE 202 187 9 9
WARFARIN SODIUM 190 127 10 15
ATORVASTATIN CALCIUM 187 150 11 13
FUROSEMIDE 186 164 12 8
ZOLPIDEM TARTRATE 133 88 13 14
TEMAZEPAM 132 131 14 47
GABAPENTIN 129 107 15 17
POTASSIUM CHLORIDE 125 107 16 24
AMOX TR-POTASSIUM CLAVULANATE 123 101 17 118
SERTRALINE HCL 118 101 18 27
GLYBURIDE-METFORMIN HCL 115 115 R 19 94
ATENOLOL 111 99 20 10
CLOPIDOGREL 99 90 21 26
ALENDRONATE SODIUM 97 97 22 23
CIPROFLOXACIN HCL 96 81 23 53
GLYBURIDE 95 84 R 24 54
CARVEDILOL 93 74 25 20
DIOVAN 89 82 26 40
GLIPIZIDE 87 84 27 41
GLIMEPIRIDE 82 74 28 45
DONEPEZIL HCL 82 82 28 30
CLONIDINE HCL 81 71 30 46
PREDNISONE 79 75 31 43
CRESTOR 76 76 32 19
FENOFIBRATE 76 71 32 50
PLAVIX 75 71 34 39
NAMENDA 73 61 35 49
CLARITHROMYCIN 71 60 36 431
QUETIAPINE FUMARATE 71 64 36 89
OXYCODONE-ACETAMINOPHEN 70 67 S2 38 91
CLOTRIMAZOLE-BETAMETHASONE 70 54 38 84
PRAVASTATIN SODIUM 69 63 40 16
NEXIUM 69 56 40 44
LOSARTAN POTASSIUM 67 59 42 11
HYDROCODONE-ACETAMINOPHEN 66 49 S3 43 12
ALPRAZOLAM 65 62 44 31
NOVOLOG 62 60 45 123
TRIAMTERENE-HCTZ 61 54 46 58
NIFEDIPINE ER 61 54 46 67
SPIRONOLACTONE 60 52 48 77
ALLOPURINOL 60 46 48 37
METOPROLOL SUCCINATE 59 59 50 18
AZITHROMYCIN 57 47 51 34
TAMSULOSIN HCL 57 49 51 28
DIOVAN HCT 57 52 51 80
SYNTHROID 56 56 54 42
LEVETIRACETAM 55 43 55 122
LEVOFLOXACIN 54 49 56 87
LANTUS 54 39 56 59
TRAMADOL HCL 52 41 58 22
LANTUS SOLOSTAR 51 36 59 124
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 50 60 36
ISOSORBIDE MONONITRATE ER 50 50 60 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.